Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keiichi Oda

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|February 23, 2013
Occupancy of α7 Nicotinic Acetylcholine Receptors in the Brain by Tropisetron: A Positron Emission Tomography Study Using [(11)C]CHIBA-1001 in Healthy Human SubjectsMasatomo Ishikawa, Muneyuki Sakata, Jun Toyohara, et al.
Nuclear Medicine and Biology|April 12, 2005
Preclinical and clinical evaluation of O-[11C]methyl-L-tyrosine for tumor imaging by positron emission tomographyKiichi Ishiwata, Hideo Tsukada, Kazuo Kubota, et al.
Nuclear Medicine and Biology|April 4, 2002
Positron emission tomography and ex vivo and in vitro autoradiography studies on dopamine D2-like receptor degeneration in the quinolinic acid-lesioned rat striatum: comparison of [11C]raclopride, [11C]nemonapride and [11C]N-methylspiperoneKiichi Ishiwata, Nobuo Ogi, Nobutaka Hayakawa, et al.
Annals of Nuclear Medicine|January 2, 2003
Adenosine A2A receptor imaging with [11C]KF18446 PET in the rat brain after quinolinic acid lesion: comparison with the dopamine receptor imagingKiichi Ishiwata, Nobuo Ogi, Nobutaka Hayakawa, et al.
Annals of Nuclear Medicine|January 14, 2022
New standards for phantom image quality and SUV harmonization range for multicenter oncology PET studiesGo Akamatsu, Naoki Shimada, Keiichi Matsumoto, et al.
Nuclear Medicine and Biology|December 26, 2012
Preclinical and the first clinical studies on [11C]ITMM for mapping metabotropic glutamate receptor subtype 1 by positron emission tomographyJun Toyohara, Muneyuki Sakata, Masayuki Fujinaga, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 28, 2013
Initial human PET studies of metabotropic glutamate receptor type 1 ligand 11C-ITMMJun Toyohara, Muneyuki Sakata, Keiichi Oda, et al.
Annals of Nuclear Medicine|December 1, 2006
A feasibility study of [11C]SA4503-PET for evaluating sigmal receptor occupancy by neuroleptics: the binding of haloperidol to sigma1 and dopamine D2-like receptorsKiichi Ishiwata, Kenji Oda, Muneyuki Sakata, et al.
Clinical Nuclear Medicine|August 21, 2014
Clinical benefit of 11C methionine PET imaging as a planning modality for radiosurgery of previously irradiated recurrent brain metastasesToshiya Momose, Tadashi Nariai, Takuya Kawabe, et al.
EJNMMI Physics|October 27, 2016
Evaluation of spatial dependence of point spread function-based PET reconstruction using a traceable point-like <sup>22</sup>Na sourceTaisuke Murata, Kenta Miwa, Noriaki Miyaji, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|February 23, 2013
Occupancy of α7 Nicotinic Acetylcholine Receptors in the Brain by Tropisetron: A Positron Emission Tomography Study Using [(11)C]CHIBA-1001 in Healthy Human SubjectsMasatomo Ishikawa, Muneyuki Sakata, Jun Toyohara, et al.
Nuclear Medicine and Biology|April 12, 2005
Preclinical and clinical evaluation of O-[11C]methyl-L-tyrosine for tumor imaging by positron emission tomographyKiichi Ishiwata, Hideo Tsukada, Kazuo Kubota, et al.
Nuclear Medicine and Biology|April 4, 2002
Positron emission tomography and ex vivo and in vitro autoradiography studies on dopamine D2-like receptor degeneration in the quinolinic acid-lesioned rat striatum: comparison of [11C]raclopride, [11C]nemonapride and [11C]N-methylspiperoneKiichi Ishiwata, Nobuo Ogi, Nobutaka Hayakawa, et al.
Annals of Nuclear Medicine|January 2, 2003
Adenosine A2A receptor imaging with [11C]KF18446 PET in the rat brain after quinolinic acid lesion: comparison with the dopamine receptor imagingKiichi Ishiwata, Nobuo Ogi, Nobutaka Hayakawa, et al.
Annals of Nuclear Medicine|January 14, 2022
New standards for phantom image quality and SUV harmonization range for multicenter oncology PET studiesGo Akamatsu, Naoki Shimada, Keiichi Matsumoto, et al.
Nuclear Medicine and Biology|December 26, 2012
Preclinical and the first clinical studies on [11C]ITMM for mapping metabotropic glutamate receptor subtype 1 by positron emission tomographyJun Toyohara, Muneyuki Sakata, Masayuki Fujinaga, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 28, 2013
Initial human PET studies of metabotropic glutamate receptor type 1 ligand 11C-ITMMJun Toyohara, Muneyuki Sakata, Keiichi Oda, et al.
Annals of Nuclear Medicine|December 1, 2006
A feasibility study of [11C]SA4503-PET for evaluating sigmal receptor occupancy by neuroleptics: the binding of haloperidol to sigma1 and dopamine D2-like receptorsKiichi Ishiwata, Kenji Oda, Muneyuki Sakata, et al.
Clinical Nuclear Medicine|August 21, 2014
Clinical benefit of 11C methionine PET imaging as a planning modality for radiosurgery of previously irradiated recurrent brain metastasesToshiya Momose, Tadashi Nariai, Takuya Kawabe, et al.
EJNMMI Physics|October 27, 2016
Evaluation of spatial dependence of point spread function-based PET reconstruction using a traceable point-like <sup>22</sup>Na sourceTaisuke Murata, Kenta Miwa, Noriaki Miyaji, et al.
Pageof 11